Impact of chemotherapy relative dose intensity on cause-specific and overall survival for stage I-III breast cancer: ER+/PR+, HER2- vs. triple-negative.

Zhang, Lu; Yu, Qingzhao; Wu, Xiao-Cheng; Hsieh, Mei-Chin; Loch, Michelle; Chen, Vivien W; Fontham, Elizabeth; Ferguson, Tekeda

Zhang, Lu; Yu, Qingzhao; Wu, Xiao-Cheng; Hsieh, Mei-Chin; Loch, Michelle; Chen, Vivien W; Fontham, Elizabeth; Ferguson, Tekeda.

Afiliação

Zhang L; Epidemiology program, School of Public Health and Louisiana Tumor Registry, Louisiana State University Health Sciences Center, New Orleans, LA, 70112, USA.
Yu Q; Biostatistics program, School of Public Health and Louisiana Tumor Registry, Louisiana State University Health Sciences Center, New Orleans, LA, 70112, USA.
Wu XC; Epidemiology program, School of Public Health and Louisiana Tumor Registry, Louisiana State University Health Sciences Center, New Orleans, LA, 70112, USA.
Hsieh MC; Epidemiology program, School of Public Health and Louisiana Tumor Registry, Louisiana State University Health Sciences Center, New Orleans, LA, 70112, USA.
Loch M; School of Medicine, Louisiana State University Health Sciences Center, New Orleans, LA, 70112, USA.
Chen VW; Epidemiology program, School of Public Health and Louisiana Tumor Registry, Louisiana State University Health Sciences Center, New Orleans, LA, 70112, USA.
Fontham E; Epidemiology program, School of Public Health and Louisiana Tumor Registry, Louisiana State University Health Sciences Center, New Orleans, LA, 70112, USA.
Ferguson T; Epidemiology program, School of Public Health and Louisiana Tumor Registry, Louisiana State University Health Sciences Center, New Orleans, LA, 70112, USA. Tferg4@lsuhsc.edu.

Breast Cancer Res Treat ; 169(1): 175-187, 2018 May.

Article em En | MEDLINE | ID: mdl-29368311

Assuntos

Neoplasias da Mama/tratamento farmacológico; Receptor ErbB-2/genética; Receptores de Estrogênio/genética; Receptores de Progesterona/genética; Neoplasias de Mama Triplo Negativas/tratamento farmacológico; Adulto; Idoso; Neoplasias da Mama/genética; Neoplasias da Mama/patologia; Intervalo Livre de Doença; Relação Dose-Resposta a Droga; Feminino; Humanos; Estimativa de Kaplan-Meier; Pessoa de Meia-Idade; Estadiamento de Neoplasias; Neoplasias de Mama Triplo Negativas/genética; Neoplasias de Mama Triplo Negativas/patologia

Palavras-chave

Breast cancer; Chemotherapy; Hormone receptor positive, Triple-negative; Relative dose intensity

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google